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Body mass index in young men and 
risk of inflammatory bowel disease 
through adult life: A population-
based Danish cohort study
Michael A. Mendall  1, Camilla B. Jensen2, Thorkild I. A. sørensen  3,4, Lars H. Ängquist2 & 
tine Jess2,5
Body mass index (BMI) is associated with increased future risk of inflammatory bowel disease(IBD) 
particularly Crohn’s disease(CD), where associations with high and low BMI have been observed. Most 
studies are based on adult women. We aimed to explore the impact of BMI in men entering adult life 
on their long-term risk of developing IBD. A total of 377,957 men born during 1939–1959, with BMI 
measured at draft boards at mean age 19, were followed from 1977, or time of examination, to end of 
2015. Risk of IBD was assessed using Cox regression. During 13 million person-years of follow-up, 1,523 
developed CD and 3,323 UC. Using normal weight as reference, for CD the following HRs were observed: 
BMI < 18.5, 1.35; 95% CI, 1.12–1.62, BMI 25–29.9; 0.83; 95% CI, 0.68–1.02. and BMI > 30 1.20; 95% CI, 
0.75–1.90). The increased risk of CD in underweight was maintained up until age 60 not explained by 
known effects of smoking. For UC, minor inverse associations were observed. Restricted cubic splines 
revealed a U-shape association between BMI and CD, but not UC. Low BMI of men entering adult life is 
associated with an increased incidence of CD and UC up to 40 years later.
Inflammatory bowel diseases are somehow diseases of modernity, although there is uncertainty as to what aspects 
of modernity are responsible. An increased prevalence of obesity occurred particularly in the late 20th century1, 
which is widely appreciated to induce a pro-inflammatory state associated with both systemic2 and local gut 
inflammation3.
It is widely appreciated that at the time of diagnosis particularly in younger subjects with Crohn’s disease that 
body mass index is reduced4–6. However in a limited number of studies, elevated body mass index associates with 
future risk of Crohn’s disease(CD) but not ulcerative colitis(UC)7–9, although to date studies have largely been in 
adult women and children8. In one prospective study in adult women10 and a case-control study in both sexes9, 
low BMI, was also associated with risk. However in a prospective study in adult women from the USA the Nurses 
Health Study(NHS)7, there was no association, although this could relate to the way low BMI was defined. Nor 
was there any association in a large study of children aged 138, although this study did observe a modest associa-
tion of low BMI with risk of UC.
Low BMI rather than being a risk factor could be a reflection of reverse causation, there being increasing 
awareness that there may be a long prodrome to Crohn’s disease (CD). Seroconversion to yeast antigens and 
elevated inflammatory markers are found up to 15 years before diagnosis11–13. There is no corresponding similar 
evidence for ulcerative colitis (UC).
The lack of association of low BMI with risk of CD in a large study of children8 raises the possibilities that 
either changes in physiology and immune function, sub-clinical disease onset, or changes in risk factor profile, 
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notably initiation of smoking, occurring at the time of puberty, could possibly explain the association with adult 
risk.
We had the unique opportunity to study a large nationally representative cohort of Danish young men, to 
assess the association of BMI with future risk of CD, for the first time prospectively in men. The possible effect of 
smoking was modelled in a sensitivity analysis.
Results
Among the 377,957 men available for inclusion in the study, the mean (SD) age at conscription board examina-
tion was 19.9 (1.7) years and the mean (SD) BMI was 21.8 (2.5) kg/m2. At this time, 6% were underweight, 85% 
were normal weight, 8% were overweight, and only 1% were obese. The descriptive statistics of the study popula-
tion are presented in Table 1.
Risk of Crohn’s disease and ulcerative colitis. During around 13 million person-years of follow up, 
1,523 men were diagnosed with CD at a mean (SD) age of 47.0 (13.0) years, and 3,323 men were diagnosed with 
UC at a mean (SD) age of 49.7 (12.0) years.
The median (IQR) time from conscription board examination to diagnosis of CD was 27.7 (6.1; 47.4) years 
and the median (IQR) time from the examination to diagnosis of UC was 31.3 (8.0; 48.3) years. There was no 
Study population
Total
N 377,957
Age (y), mean (SD) 19.9 (1.7)
Weight (kg), mean (SD) 68.6 (9.3)
Height (cm), mean (SD) 177.3 (6.6)
BMI (kg/m2), mean (SD) 21.8 (2.5)
Body size, n (%)
   Underweight 23,110 (6)
   Normal weight 319,496 (85)
   Overweight 31,581 (8)
   Obese 3,770 (1)
Crohn’s disease
N 1,523
Age at diagnosis (y), mean (SD) 47.0 (13.0)
Age at diagnosis (y), n (%)
   <30 189 (12)
   30–40 305 (20)
   40–50 364 (24)
   50–60 381 (25)
   >60 284 (19)
Body size, n (%)
   Underweight 125 (8)
   Normal weight 1,275 (84)
   Overweight 105 (7)
   Obese 18 (1)
Ulcerative colitis
N 3,323
Age at diagnosis (y), mean (SD) 49.7 (12.0)
Age at diagnosis (y), n (%)
   <30 227 (7)
   30-40 525 (16)
   40-50 808 (24)
   50-60 1,059 (32)
   >60 704 (21)
Body size, n (%)
   Underweight 210 (6)
   Normal weight 2,842 (86)
   Overweight 241 (7)
   Obese 30 (1)
Table 1. Characteristics of study population at time of conscription board examination.
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statistically significant difference in time to diagnosis of CD (P = 0.2) or UC (P = 0.9), between underweight, 
normal weight, overweight, and obese cases.
BMI categories. We further investigated the association between BMI and, respectively, CD and UC, by using 
BMI as a categorical variable of underweight, normal weight, overweight, and obesity (Table 2).
In CD, using normal weight men as the reference group, we observed a significantly increased risk for CD in 
underweight men (HR, 1.35; 95%CI, 1.12–1.62), and no statistically significant associations with overweight (HR, 
0.83; 95%CI, 0.68–1.02) or obesity (HR, 1.20; 95%CI, 0.75–1.90) (Table 2).
In UC, when using BMI as a categorical variable, we observed a pattern similar to the one found when using 
BMI as a continuous variable, i.e. a tendency towards an inverse association with UC, although only reaching 
statistical significance in the overweight category (HR, 0.86; 95% CI, 0.75–0.98) (Table 2).
In an additional analysis, performed to facilitate comparison with the NHS, where BMI categories were defined 
differently, we subdivided the normal weight conscripts. Compared with the group with BMI 20–22.5 kg/m2, 
the risk of CD was highest in those with lowest BMI within the normal range (18.5–20 kg/m2; HR, 1.25; 95% CI, 
1.09–1.44), while being unaltered in those with highest BMI within the normal range (22.5–25 kg/m2; HR, 1.05; 
95% CI, 0.92–1.20).
BMI as a continuous measure. First, we investigated the association between BMI and risk of CD and UC, using 
BMI at the conscription board examination as a continuous variable. The association between BMI and CD 
tended to be U-shaped with significant departure from linearity (P = 0.0002, whereas the association between 
BMI and UC did not demonstrate non-linearity (P = 0.9).
Next, we estimated risk of CD based on a spline model, using mean BMI (21.8 kg/m2) as the reference level. 
We observed a statistically significant inverse association between BMI under the reference level and risk of CD, 
indicated by HRs and confidence intervals for CD above 1.0 in low weight men (Fig. 1). For BMIs above the ref-
erence level, we did not observe a significant association with risk of CD.
We further examined the association between BMI and CD according to age at diagnosis of CD. For all ages of 
CD diagnosis, we found a similar non-linear (U-shaped) pattern between conscript BMI and risk of CD. Notably, 
this non-linear association between BMI in young adulthood and later risk of CD existed up to age 60 years at CD 
diagnosis (Fig. 2). A BMI of 18.0 kg/m2 at age 19 years associated with an up to 2-fold increased risk of CD in men 
diagnosed in their 40ies and 50ies.
For UC, we observed a statistically significant inverse linear association with BMI (Fig. 3). For each 1 kg/m2 
increase in BMI, the HR of UC decreased by 2% (HR, 0.98; 95% CI, 0.97–1.00). However, effect-sizes stayed quite 
modest with less than 10% increase in risk of UC for a BMI of 18 kg/m2 and 15% decrease in risk of UC for a BMI 
of 30 kg/m2 (Fig. 4).
Crohn’s disease
P
Ulcerative colitis
PCases HR (95% CI) Cases HR (95% CI)
Body size
   Underweight 125 1.35 (1.12;1.62) 0.001 210 1.03 (0.90;1.19) 0.6
   Normal weight 1,275 Reference 2,842 Reference
   Overweight 105 0.83 (0.68;1.02) 0.07 241 0.86 (0.75;0.98) 0.02
   Obese 18 1.20 (0.75;1.90) 0.5 30 0.91 (0.63;1.30) 0.6
Table 2. Hazard ratio (95% CI) of Crohn’s disease and ulcerative colitis by body size at conscription board 
examination.
Figure 1. Hazard ratio(95%CI) of Crohn’s disease by BMI at conscription board examination. Reference level is 
mean BMI of 21.8 kg/m2.
4Scientific RepoRts |          (2019) 9:6360  | https://doi.org/10.1038/s41598-019-42642-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 2. Hazard ratio(95%CI) of Crohn’s disease by BMI at conscription board examination presented by age 
at diagnosis. Reference level is mean BMI of 21.8 kg/m2.
Figure 3. Hazard ratio(95%CI) of ulcerative colitis by BMI at conscription board examination.
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Sensitivity analyses. 
 (i) The effect of smoking
Assuming (1) no true BMI-effect on CD, (2) that the prevalence of smoking was 70% (the prevalence in 
Denmark in 196014 in the study population), and (3) that the association between smoking and CD cor-
responded to HR = 2.0 (estimates ranging from 1.3–1.7 in the literature15), smoking had to be associated 
with a 4.8 kg/m2 decrease in BMI to fully explain the observed result of increased risk of CD in under-
weight men. When changing the prevalence of smoking to 50% (1980s Denmark14), smoking would have 
to be associated with a decrease in BMI of 3.9 kg/m2 to fully explain the observed results.
 (ii) Other sensitivity analyses
 We excluded potential prevalent IBD cases by postponing start of follow up from 1/1/1977 to 1/1/1980. 
The patterns of association were virtually unchanged (Supplementary Figs 2 and 3). In a further sensitivity 
analysis, restricting the cohort to those men recruited between 1/1/1977 (the beginning of the NPR) and 
31/12/1984 (the end of Draft Board examination), a similar non-linear association was observed between 
BMI and CD risk (Supplementary Fig. 4).
The association between BMI and UC was also consistent with main findings in sensitivity analyses 
(Supplementary Fig. 5).
Discussion
In this population-based cohort study of 377,957 men followed from early adulthood up to age 50+ years, we 
have demonstrated, that underweight at mean age 19 is associated with an increased long-term risk of CD. The 
association did not decrease in magnitude with increasing time-to-diagnosis until the age of 60. The association 
was non-linear with a tendency, although not significant, for risk to rise with higher BMI, but power was limited 
in this latter group. For UC, we observed a statistically significant negative linear association with BMI through-
out its range. Smoking to fully explain our findings would have had had to be associated with an implausibly large 
effect on BMI.
Previous literature on the subject is sparse, especially in men. A single smaller prospective study suggested 
no association between BMI and risk of IBD in men and women16, whereas two studies in women reported an 
association between elevated BMI and increased risk of CD, but not UC7. The DNBC study, which was based on 
younger Danish women, additionally provided evidence that low as well as high BMI was a risk factor for a diag-
nosis of CD before the age of 4010 as did an earlier case-control study. In the present study, with longer follow-up 
after BMI measurement, low BMI was found to be a risk factor for the development of CD up to the age of 60. This 
may also relate to sex-differences in the association between BMI and disease risk.
Categorization of BMI may influence results. In the NHS population from the US with a higher prevalence of 
overweight, and a lower prevalence of smoking, low BMI at baseline was not statistically significantly associated 
with CD risk (HR, 1.14; 95% CI, 0.81–1.60), but the lowest BMI category was defined by BMI < 20 kg/m2, rather 
than by the WHO measure of underweight of BMI < 18.517 used in the present study. In our additional analysis 
Figure 4. Flowchart of study population.
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we found that low normal BMI (BMI18.5- < 20 kg/m2) was associated with an almost identical HR to that seen in 
the Nurses’ Health Study for BMI < 20.
In the only study in children, aged 7–13 years, from the Copenhagen School Health Records Register 
(CSHRR), BMI was positively associated with CD diagnosed before the age of 30, but not thereafter. Notably, low 
BMI did not associate with CD for either sex among school children, nor was there any evidence of a non-linear 
association, despite the fact that children were drawn from the same population as the conscripts of the present 
study18. There was however a modest association of low BMI with risk of UC.
There are a number of potential explanations as to why low BMI should emerge as a risk factor for CD only 
after puberty. It could be due to a change in risk factor profile during adolescence, the most important of these 
being smoking, which may associate with both decreased BMI and increased risk of CD. However, for UC, in 
whom smoking is protective, the risk decreased with increasing BMI, which is counter to what would be expected 
if smoking behavior was an influence on low BMI in this cohort. Other current evidence speaks against a strong 
association between smoking and BMI in young adulthood19. The Surgeon General’s report20 indicated that for 
smokers aged 18 or younger, BMI was the same or higher in smokers, with reductions in BMI only emerging 
after the age of 35. Furthermore, the association between low BMI and CD observed among young women in the 
DNBC study was only modestly attenuated after controlling for smoking10, and there was no effect of controlling 
for smoking on the effect of BMI in the NHS6. Finally, in a recent study from the UK General Practice Research 
Database exploring whether smoking explained the U-shaped association between BMI and mortality, exclusion 
of ever smokers did not attenuate the asssociations observed which included non-liver GI diseases as an undif-
ferentiated group21. Combined with our simulations presented under the sensitivity analyses, we find it unlikely 
that the observed association is explained by smoking alone, although smokers who are pre-disposed to excessive 
weight loss may be at increased risk.
Another explanation is reverse causality, i.e. that low BMI in young adulthood reflects early sub-clinical dis-
ease manifesting around the time of completion of puberty. Elevated ASCA are present many years prior to diag-
nosis of CD12 and elevations in serum C-reactive protein and IL-6 are present up to 15 years prior to diagnosis11. 
Further evidence of a prolonged pre-clinical phase comes from family studies in CD demonstrating increased 
intestinal permeability and fecal calprotectin in first degree relatives who are at themselves at increased risk of 
developing disease22. Still, the magnitude of the reduction of BMI would be difficult to attribute to an entirely 
sub-clinical disease manifesting up to 40 years later.
Low BMI in early adulthood itself could be a risk factor for CD. Starvation23 as well as obesity24 impair gut 
barrier function and increase gut permeability which are implicated in the pathogenesis of CD25. IGF-1 levels, 
which are reduced in starvation or low protein intake26 and obesity27–29, IBD, differences in BMI, progress of 
puberty30 and sex hormone production31. In women from the NHS population, levels of free testosterone were 
strongly related to reduced future risk of CD but not UC32, with effect sizes of around a 4 fold reduction in risk in 
the 4th and 5th quintiles of serum levels compared to the lowest. Still, these hypotheses merit further investigation.
The U-shaped association between BMI and future risk of CD could be a reflection not only of U-shaped 
associations of risk factors for CD with BMI, but could reflect two different types of aetio-pathological pathways. 
There are no prospective studies on the influence of BMI on disease phenotype, although there is a suggestion 
that pure ileal disease, young age at diagnosis and no prior history of appendectomy associate with greater weight 
loss prior to and reduced BMI at the time of diagnosis33. There was no suggestion of similar U-shaped association 
of BMI with risk for UC.
Of the previous studies7,9,10,16, only the study in Danish children reported an association between BMI and 
risk of UC8. The statistically significant inverse association observed in the present study was relatively modest in 
magnitude, and former studies may have been inadequately powered to observe the association.
The primary strength of the present study is the considerable size, the geographically broad population-based 
cohort, and the long-term follow-up with minimal loss. A further strength is the validated method for ascer-
tainment of cases with case-status being defined using discharge diagnosis from the NPR that covers all Danish 
hospitals. The risk of selection bias is therefore minimal and IBD diagnoses in the NPR have been found to be 
valid and almost complete34.
Still, there are potential limitations other than the lack of ability to control for confounders discussed above 
that need consideration. The men had to be healthy enough to attend the conscription board examination33. 
Approximately 5–10% of each birth cohort was exempted from the conscription board examination, some of 
which were due to enrollment in military services before the examination and other because of various health 
conditions35, which, however, are unlikely to bias the estimates of the present study. The absence of any BMI data 
later in adulthood is another weakness, but BMI at entrance to adult life is known to track BMI in later adult life36 
and is associated with other hard clinical endpoints such as cardiovascular and cancer death many decades into 
the future37,38. It would have been ideal to have direct measures of fat and lean body mass and visceral adiposity 
which associate more strongly with the immunological phenomena associated with obesity39. However, these 
were not available, and would most likely serve to strengthen the observed association.
Some of the men were included before establishment of the NPR in 1977, which may explain the relatively 
high median age at IBD diagnosis in this study due to initial inclusion of prevalent cases, who had been diagnosed 
years before. Sensitivity analyses excluding prevalent cases (with first recorded diagnosis <1980) did not alter our 
findings. Restricting the analysis to men who had their baseline evaluation after 1976, when the NPR was estab-
lished, again did not alter the findings, thereby supporting that the association between low BMI and risk of CD 
up until the age of 60 is not explained by misclassification of age at diagnosis. This also provides reassurance that 
milder cases diagnosed before 1977, who subsequently did require hospitalization, do not introduce bias. Finally, 
few cases were obese, leaving limited power to study this aspect.
In conclusion, our population-based cohort study of 377,957 men followed from age 19 showed a U shaped 
association between BMI and risk of CD with a significant association between underweight in young adulthood 
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and later risk of CD, which persisted long-term. A more modest linear long-term association with reduced BMI 
was observed with UC. We are unable confidently to attribute all of the associations to confounding from conven-
tional risk factors in particular smoking, although it is likely that it played some part. Differences in host physi-
ology and immune function occurring at the end of maturation, likely related to hormonal milieu, may explain 
our findings, although we cannot preclude an early pre-clinical phase of CD, although this is less likely for UC.
Methods
Study population. The study population was drawn from the DCD, which is a nationwide population-based 
cohort of ethnically homogenous men examined by the conscription board from 1957 through 198440. When 
turning 18 years, all men in Denmark were required to attend the conscription board examination, which 
included a health status, measurement of height and weight, information on educational level, and cognitive 
ability assessed by an intelligence test. The total DCD population consisted of 728,160 men. Figure 4 shows the 
development of the final cohort for analysis of 377,957 men. We excluded 30,226 men with missing or outlier 
information on birth year or age at conscription board examination and 10,825 men who emigrated, deceased, or 
were lost to follow up prior to the examination or 1/1/1977, when the NPR was established. Fifty-one men were 
diagnosed with IBD before they attended the examination, 284,009 men had a missing measure weight because 
weight was not recorded in some regions, with a smaller number (25,901) having missing height.
BMI was calculated as weight divided by height-squared (kg/m2). Data was checked for outliers and one 
extreme outlier (BMI of 85 kg/m2) was removed. We defined categories of body size according to the WHO defi-
nition of underweight (BMI < 18.5), normal weight (18.5 ≤ BMI < 25), overweight (25 ≤ BMI < 30), and obesity 
(BMI ≥ 30)7.
Data linkage. In April 1968, the Danish Civil Registration System assigned a unique personal identification 
number to all Danish citizens alive and residing in Denmark and has assigned such a number to all born in Denmark 
after that date. Using the personal identification number, we obtained vital statistics of all the men and through 
linkage to the National Patient Register (NPR), we obtained diagnoses of IBD. Starting on 1/1/1977, the NPR holds 
discharge diagnosis based on the ICD coding system (versions 8 and 10). Based on the ICD codes for CD (ICD-8: 
563.00–563.09. ICD-10: K50) and UC (ICD-8: 563.19 + 569.04. ICD-10: K51) we identified incident cases of IBD. 
Patients who, over time, shifted from one IBD diagnosis to another were counted as having the latest recorded diag-
nosis, but included as cases from the date of the first IBD diagnosis. Only cases diagnosed after conscription board 
examination were included. IBD diagnoses based on the NPR are almost complete and of high validity34.
Statistical analyses. We used the Cox proportional hazards regression model to examine the association 
between BMI at conscription and risk of CD and UC, respectively. We modelled BMI as a continuous variable 
and as a categorical variable of underweight, normal weight, overweight, and obese. The normal weight group 
was used as the reference in main analyses. In an additional analysis to facilitate comparison with the NHS, the 
normal weight group was subdivided into smaller groups (18.5–20, 20–22.5, and 22.5–25 kg/m2) and the heavier 
subgroup (BMI 22.5–25 kg/m2) was used as reference. The underlying time scale was age. The men examined were 
born during a period of 21 years. To control for the increasing prevalence of overweight and obesity, we strat-
ified the analyses by 5-year birth cohorts to allow the baseline hazard to differ by birth cohort. No interactions 
between birth cohort and BMI on the risk of CD and UC were found (P for interaction 0.8 for CD and 0.1 for UC; 
Supplementary Material 1).
Furthermore, birth year was included in the model as an explanatory variable, together with age at conscrip-
tion board examination, both as continuous variables.
We checked the proportional hazards assumption by testing if the association between BMI and IBD varied 
within age-at-risk groups (<30, 30–40, 40–50, 50–60, and >60 years) using likelihood ratio tests. No violations 
of the proportional hazards assumptions were detected (all P > 0.5). We checked the association for non-linearity 
using a restricted cubic spline with 3 knots (25th, 50th and 75th percentile) and the likelihood ratio test. We also 
checked linearity using restricted cubic splines with 4 and 5 knots, and found that the model did not explain 
much additional variation when using more knots (data not shown). Time-to-diagnoses was described using 
median (interquartile range; IQR) and compared between groups by Kruskal-Wallis test.
In an attempt to estimate the likelihood of bias from smoking in the observed association between BMI and 
CD, we performed a series of simulations based on varying assumptions. For simplicity, we assumed a linear asso-
ciation - on the log-hazard scale - between BMI and CD, which was estimated to be approximately true for the 
association below BMI 21.8 kg/m2, with respect to an estimated approximate effect of HR = 1.11 per BMI-unit.
We performed additional sensitivity analyses in which we excluded potential prevalent cases in the NPR by 
postponing start of follow-up from 1/1/1977 to 1/1/1980 and also by restricting the cohort to those men whose 
baseline examination was performed between 1/1/1977 and 31/12/1984.
All statistical analyses were performed using Stata 14 (www.stata.com).
Ethics statement. This study was approved by the Danish Health Ministry. This type of research based on 
pre-existing routinely collected data does not require ethical permission in Denmark.
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